Garret Wallow

Linebacker

Age: 27
Free Agency: 2027 (UFA)
Accrued Seasons: 5
  • 2026 Salary Cap Charge: $1,075,000 (0.32% of cap)
  • 2026 Cash Payout: $1,240,000 (0.34% of spending)
  • 2026 Cash to Cap Ratio: 1.15
  • Contract Value: $1,240,000 ($1,240,000 APY)
  • Fully Guaranteed Money: $330,300
  • Contract Ranking: 113/241 at LB

Current Contract

(UFA, signed 2026)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryRoster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202627$1,215,000$25,000$330,300$1,075,0000.3%
Total$1,215,000$25,000$330,300$1,075,000

Contract Notes

Garret Wallow signed 4 year rookie contract with the Houston Texans on May 15, 2021. Contract includes $295,884 guaranteed via signing bonus.

Cash Flows

- fully earned money
- unearned or partially earned money
$1.2M
2026
Cash Due$1,240,000
Running Cash$1,240,000
Career Earnings: $3,760,939
Career APY: $752,188
Potential Earnings: $3,966,995
Total Guarantees: $626,184
Largest Cash Payment: $1,240,000 (2026)
Largest Cap Number: $1,075,000 (2026)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
TexansDraftedTerminated20214$3,775,888$943,972$295,884$1,780,88447.2%$890,442
TexansPracticeElevated20231$216,000$216,000$0$00.0%$0
TexansPracticeRenegotiated20231$216,000$216,000$0$00.0%$0
TexansSFATerminated20231$940,000$940,000$0$00.0%$0
TexansPracticeElevated20231$216,000$216,000$0$00.0%$0
TexansPracticeRenegotiated20231$216,000$216,000$0$00.0%$0
TitansSFAExpired20232$1,995,000$997,500$0$701,66735.2%$350,834
BroncosSFATerminated20251$1,100,000$1,100,000$0$00.0%$0
BroncosPracticeElevated20251$315,000$315,000$0$00.0%$0
BroncosPracticeElevated20251$402,222$402,222$0$00.0%$0
BroncosPracticeElevated20251$358,611$358,611$0$00.0%$0
BroncosPracticeRenegotiated20251$445,833$445,833$0$00.0%$0
49ersSFAExpired20251$1,100,000$1,100,000$0$244,44422.2%$244,444
BroncosSFAClaimed20251$1,100,000$1,100,000$0$00.0%$0
49ersUFAActive20261$1,240,000$1,240,000$330,300$00.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Texans2$2,121,772$1,060,886$1,632,9420.0%$488,8300.0%
Titans2$701,667$350,834$701,6670.0%$00.0%
Broncos0$693,056$0$00.0%$693,0560.0%
49ers1$244,444$244,444$244,4440.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2021Texans$660,000$73,971$0$0$733,9710.4%$955,884
2022Texans$825,000$73,971$0$0$898,9710.4%$825,000
2023Titans$940,000$0$0$0$156,6670.1%$156,667
2024Titans$1,055,000$0$0$0$545,0000.2%$545,000
202549ers$1,100,000$0$0$0$244,4440.1%$244,444
202649ers$1,215,000$0$25,000$330,300$1,075,0000.3%$1,240,000
Total$5,795,000$147,942$25,000$330,300$3,654,053$3,966,995
Dead Money History
TeamYearCap ChargeCash Paid
Texans2023$73,971$0
Texans2023$160,222$160,222
Texans2023$104,444$104,444
Texans2023$76,222$76,222
Texans2024$73,971$0
Broncos2025$200,833$200,833
Broncos2025$492,223$492,223
Total$1,181,886$1,033,944

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
DefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
202116015.7%59.7%13711210000000
202213410.6%39.9%4600101000000
2023514.2%12.8%5100000000000
20251104.2%36.3%1100000000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$227,000$1,240,000
Injury Adjusted$227,000$1,240,000
test
OTC Valuation $2.8M $5.7M $8.5M $11.3M $14.2M APY $4.2M $8.3M $12.5M $16.7M $20.8M $3,124,000 $3,725,894

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.